COMUNICADO: Se presenta en España Zebinix, un tratamiento antiepiléptico en dosis única diaria (y 3)

[17] Gabbai A, Ben-Menachem E, Maia J, et al. Long-term treatment of partial epilepsy with eslicarbazepine acetate (ESL): results of a one-year open-label extension of study BIA-2093- 302 (Abstract No. 3.208). Epilepsia. 2008;49(Suppl. 7):432-3.

[18] Elger et al. Eslicarbazepine Acetate: A Double-blind, Add-on Placebo-controlled Exploratory Trial in Adult Patients with Partial-onset SeizuresEpilepsia, 48(3):497-504, 2007

CONTACTO: Si desea más información póngase en contacto con: BenjamynTan / Helen Swift, Tonic Life Communications, +44 (0) 20 7798 9262,benjamyn.tan@toniclc.com / helen.swift@toniclc.com;Eisai Europe Ltd - Cressida Robson: +44 (0) 845 676 5318

WhatsAppFacebookTwitterLinkedinBeloudBluesky